Skip to main content
Premium Trial:

Request an Annual Quote

Cenix, Janssen Expand siRNA Delivery Collaboration

Premium

Cenix BioScience said this week that it has signed a collaboration and technology license agreement with Belgium-based Janssen Research and Development to co-develop Cenix's DARE siRNA delivery technology to improve the in vivo applicability of experiments that use the gene-silencing molecules.

According to Cenix, the deal represents an expansion of an ongoing partnership with Janssen focused on improving in vivo siRNA-based target validation methodologies in the central nervous system.

Cenix noted that certain of the technologies developed through the arrangement are expected to be useful for therapeutic siRNA delivery, as well, and will be fully owned by Cenix.

Specific terms of the arrangement were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.